Loading…

Mucoadhesive microspheres for nasal administration of cyclodextrins

The aim of this study was to examine the in vitro capacity of cyclodextrins to interfere on the β-amyloid fibril formation; then, mucoadhesive microspheres containing cyclodextrins were prepared and characterised as nasal delivery system for brain targeting. Eight batches of microspheres containing...

Full description

Saved in:
Bibliographic Details
Published in:Journal of drug targeting 2009-02, Vol.17 (2), p.168-179
Main Authors: Gavini, Elisabetta, Rassu, Giovanna, Haukvik, Tone, Lanni, Cristina, Racchi, Marco, Giunchedi, Paolo
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c465t-5af78de645592151dfd5658ff28de06b411d955131d720e6c2ec659f772ec85b3
cites cdi_FETCH-LOGICAL-c465t-5af78de645592151dfd5658ff28de06b411d955131d720e6c2ec659f772ec85b3
container_end_page 179
container_issue 2
container_start_page 168
container_title Journal of drug targeting
container_volume 17
creator Gavini, Elisabetta
Rassu, Giovanna
Haukvik, Tone
Lanni, Cristina
Racchi, Marco
Giunchedi, Paolo
description The aim of this study was to examine the in vitro capacity of cyclodextrins to interfere on the β-amyloid fibril formation; then, mucoadhesive microspheres containing cyclodextrins were prepared and characterised as nasal delivery system for brain targeting. Eight batches of microspheres containing chitosan or alginate loaded with β-cyclodextrin or hydroxypropyl-β-cyclodextrin in two different cyclodextrin to polymer ratios were produced by spray drying. The results show that none of the tested CDs has direct cellular toxicity and they protect the cell viability from β-peptide. The microspheres prepared are characterised by small particle sizes, ability to absorb water and to delay the in vitro dissolution rate of the CDs; good ex vivo mucoadhesive properties of the formulations are assessed. The microsphere properties are influenced by the kind of polymer, of cyclodextrin and by cyclodextrin to polymer ratio used. In particular, the alginate formulation containing the higher cyclodextrin content shows the best performance.
doi_str_mv 10.1080/10611860802556842
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1080_10611860802556842</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20363103</sourcerecordid><originalsourceid>FETCH-LOGICAL-c465t-5af78de645592151dfd5658ff28de06b411d955131d720e6c2ec659f772ec85b3</originalsourceid><addsrcrecordid>eNp9kEtLxDAUhYMoPkZ_gBvpRnfV3GSStuhGBl-guFFwVzJ5MBnSZkxadf69KTMqIri6h8t3DvcehA4BnwIu8RlgDlDyJAljvByTDbQLmFQ5oRRvDppDnoCXHbQX4xxjoBzwNtqBsioZw3wXTR566YWa6WjfdNZYGXxczHTQMTM-ZK2IwmVCNba1sQuis77NvMnkUjqv9EcXbBv30ZYRLuqD9Ryh5-urp8ltfv94cze5vM_lmLMuZ8IUpdJ8zFhFgIEyinFWGkPSFvPpGEBVjAEFVRCsuSRaclaZokiiZFM6Qier3EXwr72OXd3YKLVzotW-jzXBlFPANIGwAodvYtCmXgTbiLCsAddDc_Wf5pLnaB3eTxutfhzrqhJwvAZElMKZIFpp4zdHALMKiiHoYsXZNjXYiHcfnKo7sXQ-fJnof3ec_7LPtHDdTIqg67nvQ5sK_ueLTxqkmyQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20363103</pqid></control><display><type>article</type><title>Mucoadhesive microspheres for nasal administration of cyclodextrins</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Gavini, Elisabetta ; Rassu, Giovanna ; Haukvik, Tone ; Lanni, Cristina ; Racchi, Marco ; Giunchedi, Paolo</creator><creatorcontrib>Gavini, Elisabetta ; Rassu, Giovanna ; Haukvik, Tone ; Lanni, Cristina ; Racchi, Marco ; Giunchedi, Paolo</creatorcontrib><description>The aim of this study was to examine the in vitro capacity of cyclodextrins to interfere on the β-amyloid fibril formation; then, mucoadhesive microspheres containing cyclodextrins were prepared and characterised as nasal delivery system for brain targeting. Eight batches of microspheres containing chitosan or alginate loaded with β-cyclodextrin or hydroxypropyl-β-cyclodextrin in two different cyclodextrin to polymer ratios were produced by spray drying. The results show that none of the tested CDs has direct cellular toxicity and they protect the cell viability from β-peptide. The microspheres prepared are characterised by small particle sizes, ability to absorb water and to delay the in vitro dissolution rate of the CDs; good ex vivo mucoadhesive properties of the formulations are assessed. The microsphere properties are influenced by the kind of polymer, of cyclodextrin and by cyclodextrin to polymer ratio used. In particular, the alginate formulation containing the higher cyclodextrin content shows the best performance.</description><identifier>ISSN: 1061-186X</identifier><identifier>EISSN: 1029-2330</identifier><identifier>DOI: 10.1080/10611860802556842</identifier><identifier>PMID: 18985506</identifier><language>eng</language><publisher>London: Informa UK Ltd</publisher><subject>2-Hydroxypropyl-beta-cyclodextrin ; Adhesiveness ; Adhesives - chemistry ; Alginates - chemistry ; Amyloid beta-Peptides - pharmacology ; Animals ; beta-Cyclodextrins - administration &amp; dosage ; beta-Cyclodextrins - chemistry ; Biological and medical sciences ; Brain - metabolism ; brain targeting ; Cell Line, Tumor ; Chitosan - chemistry ; Cyclodextrin ; Drug Compounding ; Drug Delivery Systems ; General pharmacology ; Humans ; Lasers ; Light ; Medical sciences ; Microscopy, Electron, Scanning ; Microspheres ; mucoadhesive microspheres ; nasal drug delivery ; Nasal Mucosa - chemistry ; nose-to-brain transport ; Particle Size ; Permeability ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Polymers - chemistry ; Scattering, Radiation ; Sheep</subject><ispartof>Journal of drug targeting, 2009-02, Vol.17 (2), p.168-179</ispartof><rights>2009 Informa UK Ltd 2009</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c465t-5af78de645592151dfd5658ff28de06b411d955131d720e6c2ec659f772ec85b3</citedby><cites>FETCH-LOGICAL-c465t-5af78de645592151dfd5658ff28de06b411d955131d720e6c2ec659f772ec85b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21059172$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18985506$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gavini, Elisabetta</creatorcontrib><creatorcontrib>Rassu, Giovanna</creatorcontrib><creatorcontrib>Haukvik, Tone</creatorcontrib><creatorcontrib>Lanni, Cristina</creatorcontrib><creatorcontrib>Racchi, Marco</creatorcontrib><creatorcontrib>Giunchedi, Paolo</creatorcontrib><title>Mucoadhesive microspheres for nasal administration of cyclodextrins</title><title>Journal of drug targeting</title><addtitle>J Drug Target</addtitle><description>The aim of this study was to examine the in vitro capacity of cyclodextrins to interfere on the β-amyloid fibril formation; then, mucoadhesive microspheres containing cyclodextrins were prepared and characterised as nasal delivery system for brain targeting. Eight batches of microspheres containing chitosan or alginate loaded with β-cyclodextrin or hydroxypropyl-β-cyclodextrin in two different cyclodextrin to polymer ratios were produced by spray drying. The results show that none of the tested CDs has direct cellular toxicity and they protect the cell viability from β-peptide. The microspheres prepared are characterised by small particle sizes, ability to absorb water and to delay the in vitro dissolution rate of the CDs; good ex vivo mucoadhesive properties of the formulations are assessed. The microsphere properties are influenced by the kind of polymer, of cyclodextrin and by cyclodextrin to polymer ratio used. In particular, the alginate formulation containing the higher cyclodextrin content shows the best performance.</description><subject>2-Hydroxypropyl-beta-cyclodextrin</subject><subject>Adhesiveness</subject><subject>Adhesives - chemistry</subject><subject>Alginates - chemistry</subject><subject>Amyloid beta-Peptides - pharmacology</subject><subject>Animals</subject><subject>beta-Cyclodextrins - administration &amp; dosage</subject><subject>beta-Cyclodextrins - chemistry</subject><subject>Biological and medical sciences</subject><subject>Brain - metabolism</subject><subject>brain targeting</subject><subject>Cell Line, Tumor</subject><subject>Chitosan - chemistry</subject><subject>Cyclodextrin</subject><subject>Drug Compounding</subject><subject>Drug Delivery Systems</subject><subject>General pharmacology</subject><subject>Humans</subject><subject>Lasers</subject><subject>Light</subject><subject>Medical sciences</subject><subject>Microscopy, Electron, Scanning</subject><subject>Microspheres</subject><subject>mucoadhesive microspheres</subject><subject>nasal drug delivery</subject><subject>Nasal Mucosa - chemistry</subject><subject>nose-to-brain transport</subject><subject>Particle Size</subject><subject>Permeability</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Polymers - chemistry</subject><subject>Scattering, Radiation</subject><subject>Sheep</subject><issn>1061-186X</issn><issn>1029-2330</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNp9kEtLxDAUhYMoPkZ_gBvpRnfV3GSStuhGBl-guFFwVzJ5MBnSZkxadf69KTMqIri6h8t3DvcehA4BnwIu8RlgDlDyJAljvByTDbQLmFQ5oRRvDppDnoCXHbQX4xxjoBzwNtqBsioZw3wXTR566YWa6WjfdNZYGXxczHTQMTM-ZK2IwmVCNba1sQuis77NvMnkUjqv9EcXbBv30ZYRLuqD9Ryh5-urp8ltfv94cze5vM_lmLMuZ8IUpdJ8zFhFgIEyinFWGkPSFvPpGEBVjAEFVRCsuSRaclaZokiiZFM6Qier3EXwr72OXd3YKLVzotW-jzXBlFPANIGwAodvYtCmXgTbiLCsAddDc_Wf5pLnaB3eTxutfhzrqhJwvAZElMKZIFpp4zdHALMKiiHoYsXZNjXYiHcfnKo7sXQ-fJnof3ec_7LPtHDdTIqg67nvQ5sK_ueLTxqkmyQ</recordid><startdate>20090201</startdate><enddate>20090201</enddate><creator>Gavini, Elisabetta</creator><creator>Rassu, Giovanna</creator><creator>Haukvik, Tone</creator><creator>Lanni, Cristina</creator><creator>Racchi, Marco</creator><creator>Giunchedi, Paolo</creator><general>Informa UK Ltd</general><general>Taylor &amp; Francis</general><general>Informa Healthcare</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20090201</creationdate><title>Mucoadhesive microspheres for nasal administration of cyclodextrins</title><author>Gavini, Elisabetta ; Rassu, Giovanna ; Haukvik, Tone ; Lanni, Cristina ; Racchi, Marco ; Giunchedi, Paolo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c465t-5af78de645592151dfd5658ff28de06b411d955131d720e6c2ec659f772ec85b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>2-Hydroxypropyl-beta-cyclodextrin</topic><topic>Adhesiveness</topic><topic>Adhesives - chemistry</topic><topic>Alginates - chemistry</topic><topic>Amyloid beta-Peptides - pharmacology</topic><topic>Animals</topic><topic>beta-Cyclodextrins - administration &amp; dosage</topic><topic>beta-Cyclodextrins - chemistry</topic><topic>Biological and medical sciences</topic><topic>Brain - metabolism</topic><topic>brain targeting</topic><topic>Cell Line, Tumor</topic><topic>Chitosan - chemistry</topic><topic>Cyclodextrin</topic><topic>Drug Compounding</topic><topic>Drug Delivery Systems</topic><topic>General pharmacology</topic><topic>Humans</topic><topic>Lasers</topic><topic>Light</topic><topic>Medical sciences</topic><topic>Microscopy, Electron, Scanning</topic><topic>Microspheres</topic><topic>mucoadhesive microspheres</topic><topic>nasal drug delivery</topic><topic>Nasal Mucosa - chemistry</topic><topic>nose-to-brain transport</topic><topic>Particle Size</topic><topic>Permeability</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Polymers - chemistry</topic><topic>Scattering, Radiation</topic><topic>Sheep</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gavini, Elisabetta</creatorcontrib><creatorcontrib>Rassu, Giovanna</creatorcontrib><creatorcontrib>Haukvik, Tone</creatorcontrib><creatorcontrib>Lanni, Cristina</creatorcontrib><creatorcontrib>Racchi, Marco</creatorcontrib><creatorcontrib>Giunchedi, Paolo</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Journal of drug targeting</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gavini, Elisabetta</au><au>Rassu, Giovanna</au><au>Haukvik, Tone</au><au>Lanni, Cristina</au><au>Racchi, Marco</au><au>Giunchedi, Paolo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mucoadhesive microspheres for nasal administration of cyclodextrins</atitle><jtitle>Journal of drug targeting</jtitle><addtitle>J Drug Target</addtitle><date>2009-02-01</date><risdate>2009</risdate><volume>17</volume><issue>2</issue><spage>168</spage><epage>179</epage><pages>168-179</pages><issn>1061-186X</issn><eissn>1029-2330</eissn><abstract>The aim of this study was to examine the in vitro capacity of cyclodextrins to interfere on the β-amyloid fibril formation; then, mucoadhesive microspheres containing cyclodextrins were prepared and characterised as nasal delivery system for brain targeting. Eight batches of microspheres containing chitosan or alginate loaded with β-cyclodextrin or hydroxypropyl-β-cyclodextrin in two different cyclodextrin to polymer ratios were produced by spray drying. The results show that none of the tested CDs has direct cellular toxicity and they protect the cell viability from β-peptide. The microspheres prepared are characterised by small particle sizes, ability to absorb water and to delay the in vitro dissolution rate of the CDs; good ex vivo mucoadhesive properties of the formulations are assessed. The microsphere properties are influenced by the kind of polymer, of cyclodextrin and by cyclodextrin to polymer ratio used. In particular, the alginate formulation containing the higher cyclodextrin content shows the best performance.</abstract><cop>London</cop><pub>Informa UK Ltd</pub><pmid>18985506</pmid><doi>10.1080/10611860802556842</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1061-186X
ispartof Journal of drug targeting, 2009-02, Vol.17 (2), p.168-179
issn 1061-186X
1029-2330
language eng
recordid cdi_crossref_primary_10_1080_10611860802556842
source Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)
subjects 2-Hydroxypropyl-beta-cyclodextrin
Adhesiveness
Adhesives - chemistry
Alginates - chemistry
Amyloid beta-Peptides - pharmacology
Animals
beta-Cyclodextrins - administration & dosage
beta-Cyclodextrins - chemistry
Biological and medical sciences
Brain - metabolism
brain targeting
Cell Line, Tumor
Chitosan - chemistry
Cyclodextrin
Drug Compounding
Drug Delivery Systems
General pharmacology
Humans
Lasers
Light
Medical sciences
Microscopy, Electron, Scanning
Microspheres
mucoadhesive microspheres
nasal drug delivery
Nasal Mucosa - chemistry
nose-to-brain transport
Particle Size
Permeability
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
Polymers - chemistry
Scattering, Radiation
Sheep
title Mucoadhesive microspheres for nasal administration of cyclodextrins
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T01%3A49%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mucoadhesive%20microspheres%20for%20nasal%20administration%20of%20cyclodextrins&rft.jtitle=Journal%20of%20drug%20targeting&rft.au=Gavini,%20Elisabetta&rft.date=2009-02-01&rft.volume=17&rft.issue=2&rft.spage=168&rft.epage=179&rft.pages=168-179&rft.issn=1061-186X&rft.eissn=1029-2330&rft_id=info:doi/10.1080/10611860802556842&rft_dat=%3Cproquest_cross%3E20363103%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c465t-5af78de645592151dfd5658ff28de06b411d955131d720e6c2ec659f772ec85b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=20363103&rft_id=info:pmid/18985506&rfr_iscdi=true